Copper amino acid chelate complex - RR MedSciences

Drug Profile

Copper amino acid chelate complex - RR MedSciences

Alternative Names: Copper-XHA spray; RM 191A

Latest Information Update: 22 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator RR MedSciences
  • Class Analgesics; Neuropeptides; Organometallic compounds; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Neuropathic pain

Most Recent Events

  • 20 Jun 2017 RR MedSciences plans a pilot phase II trial for Neuropathic Pain in Australia (Topical, Spray) (ACTRN12617000206325)
  • 06 Feb 2017 Preclinical trials in Neuropathic pain in Australia (Topical) before February 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top